Dra. Berta Díaz Feijoo: “We want to help empower women in the treatment of gynaecological diseases”
She started working at the Hospital Clínic Barcelona five years ago and has been the new head of the Gynaecology Service for three months. In rece...
She started working at the Hospital Clínic Barcelona five years ago and has been the new head of the Gynaecology Service for three months. In rece...
A recent report from an organisation linked to the WHO states that talc is probably carcinogenic to humans. The use of talc is considered to increa...
A study by the Clínic-IDIBAPS shows that silencing this gene reduces the growth of liver cancer in mice. The research, using different animal model...
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved AR...
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab d...
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Program...
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.
Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to condu...
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy target...
A study led by researchers from the Clínic-IDIBAPS paves the way for the design and optimization of CAR T-cell therapy for greater effectiveness in...